Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
May 2020
Historique:
received: 04 01 2020
revised: 21 02 2020
accepted: 07 03 2020
pubmed: 17 3 2020
medline: 27 2 2021
entrez: 16 3 2020
Statut: ppublish

Résumé

Melatonin is a physiological hormone produced by the pineal gland. In recent decades, enormous investigations showed that melatonin can prompt apoptosis in cancer cells and inhibit tumor metastasis and angiogenesis in variety of malignancies such as ovarian, melanoma, colon, and breast cancer; therefore, its possible therapeutic usage in cancer treatment was confirmed. CSCs, which has received much attention from researchers in past decades, are major challenges in the treatment of cancer. Because CSCs are resistant to chemotherapeutic drugs and cause recurrence of cancer and also have the ability to be regenerated; they can cause serious problems in the treatment of various cancers. For these reasons, the researchers are trying to find a solution to destroy these cells within the tumor mass. In recent years, the effect of melatonin on CSCs has been investigated in some cancers. Given the importance of CSCs in the process of cancer treatment, this article reviewed the studies conducted on the effect of melatonin on CSCs as a solution to the problems caused by CSCs in the treatment of various cancers.

Identifiants

pubmed: 32171553
pii: S0344-0338(19)33073-0
doi: 10.1016/j.prp.2020.152919
pii:
doi:

Substances chimiques

Melatonin JL5DK93RCL

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

152919

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no competing interests.

Auteurs

Nazila Fathi Maroufi (NF)

Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Vahid Vahedian (V)

Department of Medical Laboratory Sciences, Faculty of Medicine, Islamic Azad University (IAU), Sari, Iran; Clinical Laboratory Medicine Department, Rofeydeh Hospital, University of Social Welfare and Rehabilition Sciences (USWR), Tehran, Iran.

Saideh Hemati (S)

Department of Biology, Science and Research Branch, Islamic Azad University, Iran.

Mohammad-Reza Rashidi (MR)

Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Maryam Akbarzadeh (M)

Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.

Mohammadsaeid Zahedi (M)

Bioinformatics and Computational Biology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Farhad Pouremamali (F)

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Isazadeh (A)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Sina Taefehshokr (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Saba Hajazimian (S)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Nikou Seraji (N)

Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Nouri (M)

Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: nourim@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH